Suchergebnisse - "Wang, Ning-Chi"

PubPharm (7)

1

A Phase I, Prospective, Randomized, Open-labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults

enthalten in: bioRxiv.org | 2024

von Lien, C. | Liu, M. | Wang, N. | +6

2

Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults : A Phase I, Prospective, Randomized, Open-Labeled Study

enthalten in: Vaccines | 2023

von Lien, C. | Liu, M. | Wang, N. | +6

3

Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific : Insights from the COVID-19 Pandemic

enthalten in: Clinical interventions in aging | 2023

von Woodward, M. | Ramasubramanian, V. | Kamarulzaman, A. | +11

4

A Retrospective Study of the Safety and Immunogenicity of MVC-COV1901 Vaccine for People Living with HIV

enthalten in: Vaccines | 2022

von Cheng, S. | Lien, C. | Hsieh, S. | +15

5

Safety and immunogenicity of CpG 1018 and aluminium hydroxide-adjuvanted SARS-CoV-2 S-2P protein vaccine MVC-COV1901 : interim results of a large-scale, double-blind, randomised, placebo-controlled phase 2 trial in Taiwan

enthalten in: The Lancet. Respiratory medicine | 2021

von Hsieh, S. | Liu, M. | Chen, Y. | +17

6

Safety and Immunogenicity of SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901 in People Living with HIV

enthalten in: bioRxiv.org | 2021

von Cheng, S. | Lien, C. | Hsieh, S. | +15

7

Safety and Immunogenicity of CpG 1018 and Aluminium Hydroxide-Adjuvanted SARS-CoV-2 S-2P Protein Vaccine MVC-COV1901: A Large-Scale Double-Blind, Randomised, Placebo-Controlled Phase 2 Trial

enthalten in: bioRxiv.org | 2021

von Szu-Min, H. | Liu, M. | Chen, Y. | +17

1
[1]